CH662926A5 - Brausegemisch, insbesondere fuer brausetabletten, unter seiner verwendung hergestellte brausetabletten sowie verfahren zu seiner herstellung. - Google Patents
Brausegemisch, insbesondere fuer brausetabletten, unter seiner verwendung hergestellte brausetabletten sowie verfahren zu seiner herstellung. Download PDFInfo
- Publication number
- CH662926A5 CH662926A5 CH4676/84A CH467684A CH662926A5 CH 662926 A5 CH662926 A5 CH 662926A5 CH 4676/84 A CH4676/84 A CH 4676/84A CH 467684 A CH467684 A CH 467684A CH 662926 A5 CH662926 A5 CH 662926A5
- Authority
- CH
- Switzerland
- Prior art keywords
- acid
- effervescent
- mixture
- calcium carbonate
- shower
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 55
- 238000000034 method Methods 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 112
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 56
- 239000010410 layer Substances 0.000 claims description 46
- 239000007938 effervescent tablet Substances 0.000 claims description 41
- 238000006243 chemical reaction Methods 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 30
- 239000013078 crystal Substances 0.000 claims description 22
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 21
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 21
- 239000011736 potassium bicarbonate Substances 0.000 claims description 21
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 21
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000011248 coating agent Substances 0.000 claims description 18
- 238000000576 coating method Methods 0.000 claims description 18
- 150000007524 organic acids Chemical class 0.000 claims description 18
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims description 18
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 17
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 17
- 239000003826 tablet Substances 0.000 claims description 17
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- 239000001530 fumaric acid Substances 0.000 claims description 10
- 229960005489 paracetamol Drugs 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000007789 gas Substances 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 235000014214 soft drink Nutrition 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 159000000007 calcium salts Chemical class 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 229960003975 potassium Drugs 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000033558 biomineral tissue development Effects 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000002344 surface layer Substances 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 91
- 235000015165 citric acid Nutrition 0.000 description 31
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 235000011087 fumaric acid Nutrition 0.000 description 8
- 229910001415 sodium ion Inorganic materials 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 235000017550 sodium carbonate Nutrition 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 229940093915 gynecological organic acid Drugs 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000001354 calcium citrate Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000006557 surface reaction Methods 0.000 description 3
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- -1 Citric acid Chemical class 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000021321 essential mineral Nutrition 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- OWFJMGQSOHDIPP-UHFFFAOYSA-L monocalcium citrate Chemical compound [Ca+2].OC(=O)CC(O)(C(O)=O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC([O-])=O OWFJMGQSOHDIPP-UHFFFAOYSA-L 0.000 description 2
- 235000012663 monocalcium citrate Nutrition 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- WJEIYVAPNMUNIU-UHFFFAOYSA-N [Na].OC(O)=O Chemical compound [Na].OC(O)=O WJEIYVAPNMUNIU-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000008275 binding mechanism Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000001089 mineralizing effect Effects 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT345083A AT381451B (de) | 1983-09-28 | 1983-09-28 | Brausesystem fuer brausetabletten |
DE19843434774 DE3434774A1 (de) | 1983-09-28 | 1984-09-21 | Brausegemisch, insbesondere fuer brausetabletten, unter seiner verwendung hergestellte brausetabletten sowie verfahren zu seiner herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
CH662926A5 true CH662926A5 (de) | 1987-11-13 |
Family
ID=25600062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH4676/84A CH662926A5 (de) | 1983-09-28 | 1984-09-28 | Brausegemisch, insbesondere fuer brausetabletten, unter seiner verwendung hergestellte brausetabletten sowie verfahren zu seiner herstellung. |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS6092378A (sv) |
CH (1) | CH662926A5 (sv) |
ES (1) | ES536336A0 (sv) |
FR (1) | FR2552308B1 (sv) |
GB (1) | GB2148117B (sv) |
IT (1) | IT1178516B (sv) |
SE (1) | SE462014B (sv) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0867426A2 (de) * | 1993-09-07 | 1998-09-30 | Gerhard Dr. Gergely | Modifizierte Kristalle einer festen, essbaren, organischen Säure |
EP0962443A1 (de) * | 1998-06-03 | 1999-12-08 | Gerhard Dr. Gergely | Mit Alkali- bzw. Erdalkali-Ionen dotierte Zitronensäure |
WO2016075655A1 (de) * | 2014-11-12 | 2016-05-19 | Biofar Laboratoires | Verfahren zur herstellung einer natrium-ion-freien brausetablette oder eines solchen brausepulvers oder -granulats mit hohem x-ion-gehalt, wobei x verschiedene stoffe sein können |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3440288C2 (de) * | 1984-11-05 | 1987-03-12 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung |
WO1987001936A1 (en) * | 1985-09-25 | 1987-04-09 | Gerhard Gergely | Desintegration tablet and process for its manufacture |
IT1209667B (it) * | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
DE3635864A1 (de) * | 1986-06-26 | 1988-05-05 | Gerhard Gergely | Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung |
CA2023493C (en) * | 1989-08-31 | 2000-01-04 | Masami Moroi | Composition for foaming preparation |
CA2021548A1 (en) * | 1989-09-01 | 1991-03-02 | Ronald Nash Duvall | Effervescent cold or sinus allergy medicine composition having reduced sodium content |
US5254355A (en) * | 1992-05-29 | 1993-10-19 | Kraft General Foods, Inc. | Process for beverage tablets and products therefrom |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
DE59407351D1 (de) * | 1993-09-09 | 1999-01-07 | Gerhard Gergely | Brausegranulat und verfahren zu seiner herstellung |
NL1019544C2 (nl) | 2001-12-12 | 2003-06-13 | Sara Lee De Nv | Inrichting voor het aanbieden en afgeven van voor consumptie geschikt mineraalwater. |
EP3248792B1 (en) * | 2011-03-31 | 2019-08-28 | Brother Kogyo Kabushiki Kaisha | Printing control apparatus |
US20140371174A1 (en) | 2013-06-12 | 2014-12-18 | The Procter & Gamble Company | Effervescent Dosage Form |
CN104363897A (zh) | 2012-06-12 | 2015-02-18 | 宝洁公司 | 泡腾剂型 |
JP2021098686A (ja) * | 2019-12-23 | 2021-07-01 | 花王株式会社 | 発泡剤 |
CN113813240A (zh) * | 2021-09-18 | 2021-12-21 | 博凯药业有限公司 | 一种无钠泡腾片、制备方法及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3495001A (en) * | 1968-05-27 | 1970-02-10 | Miles Lab | Effervescent compositions of acetylsalicylic acid |
AT374348B (de) * | 1980-07-01 | 1984-04-10 | Gergely Gerhard | Verfahren zur herstellung von gewuenschtenfalls zu brausetabletten verarbeitbaren brausegranulaten |
EP0076340B1 (de) * | 1981-10-06 | 1984-08-15 | Gerhard Dr. Gergely | Verfahren zur Herstellung von gewünschtenfalls zu Brausetabletten verarbeitbaren Brausegranulaten |
-
1984
- 1984-09-27 FR FR848414851A patent/FR2552308B1/fr not_active Expired - Lifetime
- 1984-09-27 JP JP59200702A patent/JPS6092378A/ja active Granted
- 1984-09-27 SE SE8404841A patent/SE462014B/sv not_active IP Right Cessation
- 1984-09-27 GB GB08424451A patent/GB2148117B/en not_active Expired
- 1984-09-28 IT IT22908/84A patent/IT1178516B/it active
- 1984-09-28 ES ES536336A patent/ES536336A0/es active Granted
- 1984-09-28 CH CH4676/84A patent/CH662926A5/de not_active IP Right Cessation
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0867426A2 (de) * | 1993-09-07 | 1998-09-30 | Gerhard Dr. Gergely | Modifizierte Kristalle einer festen, essbaren, organischen Säure |
EP0867426A3 (en) * | 1993-09-07 | 1998-11-11 | Gerhard Dr. Gergely | Modified crystals of a solid edible organic acid |
EP0962443A1 (de) * | 1998-06-03 | 1999-12-08 | Gerhard Dr. Gergely | Mit Alkali- bzw. Erdalkali-Ionen dotierte Zitronensäure |
WO1999062856A2 (de) * | 1998-06-03 | 1999-12-09 | Gerhard Gergely | Mit alkali- bzw. erdalkali-ionen dotierte zitronensäure |
WO1999062856A3 (de) * | 1998-06-03 | 2000-01-27 | Gerhard Gergely | Mit alkali- bzw. erdalkali-ionen dotierte zitronensäure |
WO2016075655A1 (de) * | 2014-11-12 | 2016-05-19 | Biofar Laboratoires | Verfahren zur herstellung einer natrium-ion-freien brausetablette oder eines solchen brausepulvers oder -granulats mit hohem x-ion-gehalt, wobei x verschiedene stoffe sein können |
US10485754B2 (en) | 2014-11-12 | 2019-11-26 | Biofar Laboratories | Method for the production of a sodium ion-free effervescent tablet, powder or granulate having a high X ion content, where X can be a variety of substances |
Also Published As
Publication number | Publication date |
---|---|
JPH0562157B2 (sv) | 1993-09-07 |
ES8603552A1 (es) | 1985-12-16 |
SE8404841D0 (sv) | 1984-09-27 |
IT1178516B (it) | 1987-09-09 |
SE8404841L (sv) | 1985-03-29 |
GB8424451D0 (en) | 1984-10-31 |
GB2148117A (en) | 1985-05-30 |
IT8422908A0 (it) | 1984-09-28 |
FR2552308A1 (fr) | 1985-03-29 |
JPS6092378A (ja) | 1985-05-23 |
GB2148117B (en) | 1987-10-21 |
ES536336A0 (es) | 1985-12-16 |
FR2552308B1 (fr) | 1991-07-05 |
SE462014B (sv) | 1990-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH662926A5 (de) | Brausegemisch, insbesondere fuer brausetabletten, unter seiner verwendung hergestellte brausetabletten sowie verfahren zu seiner herstellung. | |
EP0592484B1 (de) | Reaktionsdotierte brausesysteme | |
EP0028005B1 (de) | Reinigungstablette für Zahnprothesen | |
DE69314186T2 (de) | Brausemischungen enthaltend ibuprofen und verfahren | |
DE2058434B2 (de) | Verfahren zum Herstellen von freifließenden, leicht benetzbaren Acetylsalicylsäure enthaltenden Arzneimittelteilchen zur Bereitstellung von brausenden Zubereitungen | |
DE19617487A1 (de) | Geschmacksverbesserung von Arzneimittelwirkstoffen | |
DE3838431A1 (de) | Ibuprofen-brausezubereitungen | |
EP0687464B1 (de) | Verfahren zur Herstellung von Brausetabletten | |
EP0272312B1 (de) | Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung | |
DE69108022T2 (de) | Arzneimittel. | |
EP0717614B1 (de) | Brausegranulat und verfahren zu seiner herstellung | |
DE670160T1 (de) | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. | |
EP0287647B1 (de) | Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung | |
EP0076340B1 (de) | Verfahren zur Herstellung von gewünschtenfalls zu Brausetabletten verarbeitbaren Brausegranulaten | |
DE1962791A1 (de) | Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben | |
DE69401502T2 (de) | Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält | |
DE3434774C2 (sv) | ||
EP0922450B1 (de) | Brausezubereitung enthaltend ein Pflanzenextrakt | |
DE1617522A1 (de) | Verfahren zur Herstellung einer Arzneimittelzubereitung | |
DE3632334A1 (de) | Eisenpraeparat, dieses enthaltende brausetablette und verfahren zu deren herstellung | |
DE19637736C2 (de) | Badesprudelzusatz und Verfahren zu seiner Herstellung | |
DE744655C (de) | Verfahren zur Herstellung von Suesswaren | |
DE2065404A1 (de) | Verfahren zur herstellung von zubereitungen mit protrahierter abgabe von wirkstoffen mit bakteriziden, fungiziden oder sonstigen ausser pharmakologischen eigenschaften und zubereitungen | |
DE653323C (de) | Verfahren zur Herstellung oelhaltiger verpressbarer Massen | |
DE1915509C (de) | Verfahren zur Herstellung von organi sehen Saureknstallen, deren Oberflache aus einem dehydratisierten wasserlöslichen Salz der Saure besteht |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |